Jiani Yang
Impact in
- Cancer Research top 10%
- Biomedical Engineering top 5%
- Nanoplatforms for cancer theranostics
Papers in
-
- Circular RNAs in diseases 4
- Oncology 14
- Cancer Cells and Metastasis 4
- Cancer Immunotherapy and Biomarkers 4
- Inflammatory Biomarkers in Disease Prognosis 4
- Co-authors
- Shanshan Cheng (26 shared papers)Yanqiao Zhang (11 shared papers)Piaoping Yang (6 shared papers)Yaqian Du (6 shared papers)Fei He (5 shared papers)Yuanfei Yao (10 shared papers)Yue Jin (7 shared papers)Jun Lin (2 shared papers)
In The Last Decade
Jiani Yang
65 papers receiving 1.5k citations
Jiani Yang's Hit Papers
Peers
Comparison fields: 5 of 107
- Cancer Research 194
- Biomedical Engineering 595
- Oncology 282
- Biomaterials 137
- Reproductive Medicine 78
Countries citing papers authored by Jiani Yang
This map shows the geographic impact of Jiani Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiani Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiani Yang more than expected).
Fields of papers citing papers by Jiani Yang
This network shows the impact of papers produced by Jiani Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiani Yang. The network helps show where Jiani Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Jiani Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 68 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 166 | |
| 2 | A “Closed‐Loop” Therapeutic Strategy Based on Mutually Reinforced Ferroptosis and Immunotherapy Hit paper breakdown → | 2022 | 151 |
| 3 | 2020 | 132 | |
| 4 | A Vacancy‐Engineering Ferroelectric Nanomedicine for Cuproptosis/Apoptosis Co‐Activated Immunotherapy Hit paper breakdown → | 2024 | 83 |
| 5 | 2023 | 82 | |
| 6 | 2020 | 60 | |
| 7 | 2023 | 51 | |
| 8 | 2021 | 44 | |
| 9 | 2023 | 43 | |
| 10 | 2023 | 42 | |
| 11 | 2023 | 36 | |
| 12 | 2020 | 35 | |
| 13 | 2021 | 33 | |
| 14 | 2023 | 30 | |
| 15 | 2024 | 24 | |
| 16 | 2021 | 23 | |
| 17 | 2019 | 23 | |
| 18 | 2021 | 22 | |
| 19 | 2022 | 22 | |
| 20 | 2021 | 22 |
About Jiani Yang
Jiani Yang is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Cancer Research and Biomedical Engineering, having authored 68 papers that have together received 1.5k indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (9 papers), Nanoplatforms for cancer theranostics (9 papers), Immune cells in cancer (8 papers), Cancer Cells and Metastasis (4 papers), Circular RNAs in diseases (4 papers), Cancer Immunotherapy and Biomarkers (4 papers), Inflammatory Biomarkers in Disease Prognosis (4 papers) and Photodynamic Therapy Research Studies (3 papers). The work is most often cited by research in Cancer Research (194 citations), Biomedical Engineering (595 citations), Oncology (282 citations), Biomaterials (137 citations) and Reproductive Medicine (78 citations). Jiani Yang has collaborated with scholars based in China, Japan and Hong Kong. Frequent co-authors include Shanshan Cheng, Yanqiao Zhang, Piaoping Yang, Yaqian Du, Fei He, Yuanfei Yao, Yue Jin, Jun Lin, Yu Wang and Jinfeng Zhang. Their work appears in journals such as Advanced Science, Journal of Ovarian Research, Advanced Materials, Advanced Functional Materials and Frontiers in Cell and Developmental Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.